Cocaine-induced Pisa syndrome

Marcello Mario Mascia¹, Giovanni Defazio^{2

3}

Affiliations

¹ Department of Medical Sciences and Public Health, Institute of Neurology, University Hospital D. Casula, Monserrato, Cagliari, Italy. marcello.mas@tiscali.it.
² Department of Medical Sciences and Public Health, Institute of Neurology, University Hospital D. Casula, Monserrato, Cagliari, Italy.
³ Department of Medical Sciences and Public Health, Institute of Neurology, University of Cagliari, Cagliari, Italy.

Marcello Mario Mascia et al. Neurol Sci. 2021 Sep.

. 2021 Sep;42(9):3927-3928.

doi: 10.1007/s10072-021-05404-x. Epub 2021 Jun 19.

Marcello Mario Mascia¹, Giovanni Defazio^{2

3}

¹ Department of Medical Sciences and Public Health, Institute of Neurology, University Hospital D. Casula, Monserrato, Cagliari, Italy. marcello.mas@tiscali.it.
² Department of Medical Sciences and Public Health, Institute of Neurology, University Hospital D. Casula, Monserrato, Cagliari, Italy.
³ Department of Medical Sciences and Public Health, Institute of Neurology, University of Cagliari, Cagliari, Italy.

No abstract available

References

1. Barone P, Santangelo G, Amboni M, Pellecchia MT, Vitale C (2016) Pisa syndrome in Parkinson’s disease and parkinsonism: clinical features, pathophysiology, and treatment. Lancet Neurol 15:1063–1074. https://doi.org/10.1016/s1474-4422(16)30173-9 - DOI - PubMed
1. Suzuki T, Matsuzaka H (2002) Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management. CNS Drugs 16:165–174. https://doi.org/10.2165/00023210-200216030-00003 - DOI - PubMed
1. Goldstein RA, DesLauriers C, Burda A, Johnson-Arbor K (2009) Cocaine: history, social implications, and toxicity: a review. Semin Diagn Pathol 26:10–17. https://doi.org/10.1053/j.semdp.2008.12.001 - DOI - PubMed
1. Remington GJ (1988) The Pisa syndrome: possible role for serotonin and noradrenaline. J Clin Psychopharmacol 8:228–229 - DOI
1. Deik A, Saunders-Pullman R, San Luciano M (2012) Substance of abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev 5:243–253. https://doi.org/10.2174/1874473711205030243 - DOI - PubMed - PMC